BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 24, 2021
View Archived Issues
FDA approves IND for JAR-914 in Duchenne muscular dystrophy
Read More
Remdesivir data in pediatric patients with COVID-19
Read More
MGTA-145 plus plerixafor effectively mobilizes stem cells for transplant in phase I study
Read More
Phase II trial underway in Mali for CIS-43LS to prevent P. falciparum infection
Read More
Izcargo approved in Japan for the treatment of MPS II
Read More
U.S. researchers patent GTPase KRAS mutant inhibitors
Read More
Ofatumumab approved in Japan for multiple sclerosis
Read More
Janssen's Darzquro approved for multiple myeloma in Japan
Read More
Breyanzi CAR-T therapy receives lymphoma approvals in Japan
Read More
ChemWerth presents new JAK1 inhibitors
Read More
Bristol Myers Squibb divulges DGKA and/or DGKZ inhibitors
Read More
Idorsia Pharmaceuticals synthesizes LGALS inhibitors
Read More
Biotest presents FVIII-based recombinant proteins for hemophilia A
Read More
First trial evaluating KCNQ2/3 positive modulator ezogabine in depression and anhedonia
Read More
Japanese approval of Lenvima for unresectable thymic carcinoma
Read More
Japanese MHLW approves Remitoro for relapsed or refractory PTCL and CTCL
Read More
Basilea reports further interim data from phase II study of derazantinib in bile duct cancer
Read More
LINC-4 phase III data presented for osilodrostat in patients with Cushing's disease
Read More
GAUSS identifies subsets, improves UK Biobank interpretation
Read More
Kinase links innate immunity to MDS
Read More
Phase II data for xanomeline/trospium as therapy for patients with schizophrenia
Read More
Clover initiates phase II/III study of adjuvanted S-Trimer COVID-19 vaccine candidate
Read More
LIBERTY randomized withdrawal study of relugolix combination therapy meets primary endpoint
Read More
ProQR plans phase II/III studies with QR-421a in Usher syndrome based on phase I/II trial analysis
Read More
FDA clears IND for phase I/II trial of EO-2463 for indolent NHL
Read More
CVnCoV protects against SARS-CoV-2 B.1.351 variant in preclinical challenge study
Read More
Ostabaro approved in Japan for osteoporosis in patients at high risk of fractures
Read More